TOMI Environmental Secures $600K Contract for SteraMist System in California Life Sciences Sector

FREDERICK, Md., Feb. 29, 2024 -- TOMI Environmental Solutions, Inc. ("TOMI") (NASDAQ: TOMZ), a pioneer in disinfection and decontamination technologies, has recently inked a significant contract with a life sciences company based in California. This deal, valued at around $600,000, marks an important milestone for the deployment of TOMI's SteraMist iHP Custom Engineered System (CES) within the clinical suites of the burgeoning pharmaceutical and biotech industries in the state, with full installation expected by Q3 2024. The move reflects a broader trend towards automation in decontamination processes across the life sciences sector, aiming to adhere to stringent standards such as Annex 1, GMP, and ISO.

Emerging Trends in Decontamination

The life sciences industry is rapidly embracing automated solutions for decontamination to meet high regulatory standards. This shift not only ensures superior disinfection but also enhances workflow efficiencies by reducing laboratory downtime. TOMI's SteraMist iHP technology has been selected over traditional vaporized hydrogen peroxide methods due to its effectiveness and efficiency, as demonstrated at an ISPE event hosted by Avid Bioservices. This choice underscores the industry's confidence in SteraMist iHP's ability to provide top-notch decontamination while facilitating operational productivity.

Building Industry Relationships

Dr. Halden Shane and E.J. Shane, CEO and COO of TOMI, respectively, have emphasized the importance of fostering strong relationships within the industry. Their approach has not only facilitated the securing of the recent contract but has also opened avenues for future collaborations and opportunities within California's life sciences sector. The company's established connections with contractors and lab architects nationwide have been instrumental in positioning SteraMist iHP as the preferred technology for laboratory decontamination, proving that maintaining robust industry relationships is key to driving growth and adoption of innovative solutions.

Looking Forward

The installation of the SteraMist iHP Custom Engineered System in California is a testament to TOMI's growing influence in the life sciences decontamination market. This contract not only reinforces the company's footprint in the state but also signals the potential for increased adoption of automated decontamination technologies in laboratories worldwide. As TOMI continues to expand its network and develop its technology, the future looks promising for the company's role in ensuring high-quality decontamination in the global life sciences industry.